Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

acetylcysteine

acetylcysteine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
MucoMYST SOLUTION, INHALATION 10%, 20%      
Acetadote SOLUTION, INTRAVENOUS 20%      
Cetylev TABLET, EFFERVESCENT, ORAL 500 mg, 2.5 g      
VIEW MORE Miscellaneous Therapeutic Agents
CLASS
920000
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

acetylcysteine (MucoMYST) nebulizer solution

 

Standard Dose

  • 100 mg (0.5 mL 20% solution)

Acetylcysteine for inhalation may be administered orally.

Oral acetylcysteine (MUCOMYST) is more cost effective than IV acetylcysteine (ACETADOTE) formulations

Oral uses: contrast-induced nephropathy prophylaxis & acetaminophen poisoning

 

Acetylcysteine nebulization: If no duration is specified, acetylcysteine will be automatically adjusted to a duration of 72 hrs.  It may be re-ordered. 

The dosing interval of acetylcysteine nebulization should be adjusted to match the dosing interval/schedule of other nebulized medications (i.e. albuterol, ipratropium, levalbuterol).

 

Common Nebulized Doses for Pediatrics

Reviewed: 27 September 2016 (Cetylev)

Last updated: Mar. 22, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved